Punjab health authorities have ordered the recall of 10 batches of Lowplat Plus after laboratory testing found them to be substandard. The Directorate of Drugs Control Punjab (DDCP) issued the alert after testing by the Drug Testing Laboratory Punjab.
The affected medicine contains clopidogrel bisulphate 75mg and aspirin 75mg. It is used as an antiplatelet medicine. Authorities have told pharmacies, wholesalers, distributors and healthcare facilities to stop dispensing the specified batches.
Which Lowplat Plus Batches Are Affected?
According to the latest alert, four affected batches have an expiry date of January 2028:
- 6B300
- 6B301
- 6B268
- 6B277
Six more batches have an expiry date of February 2028:
- 6C135
- 6C136
- 6C137
- 6C138
- 6C129
- 6C270
The recall applies to these 10 batches. Authorities classified them as substandard after an impurities test by the provincial drug testing laboratory.
Authorities Order Immediate Recall
The Directorate of Drugs Control Punjab has told businesses to stop dispensing the affected batches. They must also provide details about their remaining stock and consumption records to the relevant drug inspectors.
Meanwhile, the manufacturer and market authorization holder have been directed to start the recall process. They must also provide distribution records and investigate the cause of the quality failure.
Healthcare professionals have also been asked to report any adverse effects linked to the affected batches through the provincial pharmacovigilance system.
What Should Patients Do?
Patients who have Lowplat Plus should first check the batch number printed on the medicine strip or box. If it matches one of the listed batches, they should contact their doctor or pharmacist for advice and a suitable replacement.
Lowplat Plus contains antiplatelet medicines used to help prevent blood clots and reduce the risk of serious cardiovascular events. Therefore, patients should not stop prescribed antiplatelet treatment without medical advice.
The latest Punjab alert covers the 10 specified batches. Authorities have instructed the supply chain to remove these batches from circulation. Further action may follow if the investigation identifies other affected batches.
One Response